APOLLO'S HEGEMONY NAC 500 Mg - N-Acetyl L-Cysteine 250 Vegan Capsules - 8 Month Supply - Amino Acid Dietary Supplement to Support Liver Function and Reduce Antioxidant Levels
Guarantee Safe Checkout
APOLLO'S HEGEMONY NAC 500 Mg - N-Acetyl L-Cysteine 250 Vegan Capsules - 8 Month Supply - Amino Acid Dietary Supplement to Support Liver Function and Reduce Antioxidant Levels
- ULTIMATE VALUE PACK: Containing 250 vegan capsules each with 500 mg of N-acetylcysteine, this package offers an ample supply for extensive support, lasting for nearly eight months at recommended dosages.
- SUPPORTIVE MEASURES: May contribute to enhanced vitality by supporting the body's detox processes. Its unique formulation aids in providing an environmental shield against everyday pollutants.
- PREMIUM INGREDIENTS: Each capsule is packed with high-quality N-acetylcysteine, a modified version of the amino acid L-cysteine, poised to support your natural defense mechanisms against oxidative stress.
- HIGHEST PRODUCTION STANDARDS: The product was made in a HACCP certified facility using the best manufacturing practices. They ensure the highest quality of end products that are completely safe, effective and innovative.
- PRODUCT DIRECTLY FROM THE MANUFACTURER: Apollo's Hegemony is a manufacturer of dietary supplements whose compositions are based on the latest scientific research results and many years of experience. Their task is not only to meet basic supplementation needs, but also to create market niches thanks to exclusive, rare products.
SUPER VALUE FOR MONEY: 250 vegetarian capsules with 500 mg N-acetylcysteine (NAC), i.e. a high-dose ingredient with versatile and extremely health-promoting effects. Depending on consumption (1 capsule 1-2 times daily), one pack is enough for 3-6 months of use.
Disclaimer: The statements made on this product page have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Please consult a healthcare professional before use.
